Developing new treatments for COVID-19
DEVELOPMENT OF THERAPEUTIC PRODUCTS FOR COVID-19
This study is working on a new treatment for COVID-19 and other infectious diseases that could help patients feel better and recover faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10269648 on NIH RePORTER |
What this research studies
This research focuses on creating and advancing a promising therapeutic product aimed at treating COVID-19 and other emerging infectious diseases. The approach includes optimizing the chemistry of the therapeutic candidate, ensuring good manufacturing practices, and conducting thorough safety and efficacy assessments through clinical trials. Patients may benefit from the development of new treatment options that could improve outcomes for those affected by COVID-19. The research will follow a structured product development pathway to ensure that the therapeutic reaches the market effectively.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals diagnosed with COVID-19 or those at high risk of severe disease due to underlying health conditions.
Not a fit: Patients who are not infected with COVID-19 or do not have risk factors for severe disease may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for COVID-19, improving recovery rates and reducing the severity of the disease.
How similar studies have performed: Other research efforts targeting COVID-19 therapeutics have shown promise, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Glenn, Jeffrey — Stanford University
- Study coordinator: Glenn, Jeffrey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.